These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design. Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632 [TBL] [Abstract][Full Text] [Related]
7. The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication. Panchenko E; Dobrovolsky A; Rogoza A; Sorokin E; Ageeva N; Markova L; Titaeva E; Anuchin V; Karpov Y; Saks V Int Angiol; 1994 Mar; 13(1):59-64. PubMed ID: 8077800 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication. Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942 [TBL] [Abstract][Full Text] [Related]
9. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study. Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663 [TBL] [Abstract][Full Text] [Related]
13. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication. de Haro J; Acin F; Florez A; Bleda S; Fernandez JL J Vasc Surg; 2010 Apr; 51(4):857-62. PubMed ID: 20347681 [TBL] [Abstract][Full Text] [Related]
14. The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial. Hobbs SD; Marshall T; Fegan C; Adam DJ; Bradbury AW J Vasc Surg; 2007 Jan; 45(1):65-70; discussion 70. PubMed ID: 17210383 [TBL] [Abstract][Full Text] [Related]
15. Lack of effect of a 24-hour infusion of iloprost in intermittent claudication. Hay CR; Waller PC; Carter C; Cameron HA; Parnell L; Ramsay LE; Preston FE; Greaves M Thromb Res; 1987 Apr; 46(2):317-24. PubMed ID: 2440125 [TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy. Circulation; 1989 Dec; 80(6):1544-8. PubMed ID: 2688971 [TBL] [Abstract][Full Text] [Related]
17. Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Creager MA; Olin JW; Belch JJ; Moneta GL; Henry TD; Rajagopalan S; Annex BH; Hiatt WR Circulation; 2011 Oct; 124(16):1765-73. PubMed ID: 21947297 [TBL] [Abstract][Full Text] [Related]
18. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial. Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700 [TBL] [Abstract][Full Text] [Related]
19. Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication. Walker RD; Nawaz S; Wilkinson CH; Saxton JM; Pockley AG; Wood RF J Vasc Surg; 2000 Apr; 31(4):662-9. PubMed ID: 10753273 [TBL] [Abstract][Full Text] [Related]
20. A long-term study of policosanol in the treatment of intermittent claudication. Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]